FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Chia

Research Profile

Disorders

Breast Neoplasms

Chemicals & Drugs

Geographic Areas

British Columbia

Physiology

Gene Amplification

Concepts & Ideas

Procedures

Anatomy

Chromosomes, Human, Pair 11

Co-author Network

Publications

TOP 3
Ana Elisa Lohmann; Stephen Chia
Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it?
Stephen Chia; Brian Norris; Caroline H Speers; Mary Cheang; Blake Gilks; Allen M Gown; David Huntsman; Ivo A Olivotto; Torsten O Nielsen; Karen Gelmon
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
Stephen Chia; William Gradishar
Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Chia (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Ana Elisa Lohmann; Stephen Chia
Patients with metastatic breast cancer using bevacizumab as a treatment: is there still a role for it?
Current treatment options in oncology 2012;13(2):249-62.
2008: Stephen Chia; Brian Norris; Caroline H Speers; Mary Cheang; Blake Gilks; Allen M Gown; David Huntsman; Ivo A Olivotto; Torsten O Nielsen; Karen Gelmon
Human epidermal growth factor receptor 2 overexpression as a prognostic factor in a large tissue microarray series of node-negative breast cancers.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5697-704.
2008: Stephen Chia; William Gradishar
Fulvestrant: expanding the endocrine treatment options for patients with hormone receptor-positive advanced breast cancer.
Breast (Edinburgh, Scotland) 2008;17 Suppl 3():S16-21.
2008: Stephen Chia; William Gradishar; Louis Mauriac; Jose Bines; Frederic Amant; Miriam Federico; Luis Fein; Gilles Romieu; Aman Buzdar; John F R Robertson; Adam Brufsky; Kurt Possinger; Pamela Rennie; Francisco Sapunar; Elizabeth Lowe; Martine Piccart
Double-blind, randomized placebo controlled trial of fulvestrant compared with exemestane after prior nonsteroidal aromatase inhibitor therapy in postmenopausal women with hormone receptor-positive, advanced breast cancer: results from EFECT.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(10):1664-70.
2008: A V Tinker; J Barnett; I A Olivotto; C Speers; Stephen Chia
Impact of a reduced dose intensity of adjuvant anthracycline based chemotherapy in a population-based cohort of stage I-II breast cancers.
Ecancermedicalscience 2008;2():63.
2006: Stephen Chia; Mark Clemons; Lee-Ann Martin; Angela Rodgers; Karen Gelmon; Gregory R Pond; Lawrence Panasci
Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(18):2773-8.
2006: Lindsay A Brown; Julie Irving; Robin Parker; Hanna Kim; Joshua Z Press; Teri A Longacre; Stephen Chia; anthony magliocco; Nikita Makretsov; Blake Gilks; Jonathan Pollack; David Huntsman
Amplification of EMSY, a novel oncogene on 11q13, in high grade ovarian surface epithelial carcinomas.
Gynecologic oncology 2006;100(2):264-70.
2005: Leah M Prentice; Ashleen Shadeo; Valia Lestou; Melinda A Miller; Ronald deLeeuw; Nikita Makretsov; Dmitry Turbin; Lindsay A Brown; Nicol Macpherson; Erika Yorida; Mary Cheang; John Bentley; Stephen Chia; Torsten O Nielsen; C Blake Gilks; Wan Lam; David Huntsman
NRG1 gene rearrangements in clinical breast cancer: identification of an adjacent novel amplicon associated with poor prognosis.
Oncogene 2005;24(49):7281-9.
2005: Karen Gelmon; Karl Belanger; Denis Soulieres; Carolyn Britten; Stephen Chia; Danielle Charpentier; Kim Chi; Jean Powers; Wendy Walsh; Lesley Seymour
A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) IND 130.
Investigational new drugs 2005;23(5):445-53.
2005: Dawn Waterhouse; Tetyana Denyssevych; Norma Hudon; Stephen Chia; Karen Gelmon; Marcel B Bally
Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levels.
Pharmaceutical research 2005;22(6):915-22.
2005: Stephen Chia; Cicely J Bryce; Karen Gelmon
The 2000 EBCTCG overview: a widening gap.
Lancet 2005;365(9472):1665-6.
2004: Karen Gelmon; David Stewart; Kim N Chi; Stephen Chia; Christine M Cripps; SD Huan; S Janke; D Ayers; D Fry; J A Shabbits; Wendy Walsh; Lynn McIntosh; LK Seymour
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(7):1115-22.
2004: Nikita Makretsov; May He; Malcolm Hayes; Stephen Chia; Douglas E Horsman; Poul H B Sorensen; David Huntsman
A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma.
Genes, chromosomes & cancer 2004;40(2):152-7.
2004: Shahriar Dabiri; David Huntsman; Nikita Makretsov; Mary Cheang; Blake Gilks; Chris D Bajdik; Chris Badjik; Karen Gelmon; Stephen Chia; Malcolm Hayes
The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2004;17(6):690-5.
2004: Corinna Warburton; Wieslawa H Dragowska; Karen Gelmon; Stephen Chia; Hong Yan; Dana Masin; Tetyana Denyssevych; Anne E Wallis; Marcel B Bally
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2512-24.
2003: Cicely J Bryce; Hagen Kennecke; Stephen Chia; Joseph Ragaz
Benefit of Paclitaxel in estrogen receptor-negative versus estrogen receptor-positive early breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(23):4465; author reply 4465-6.
2003: Luke Hughes-Davies; David Huntsman; Margarida Ruas; François Fuks; Jacqueline Bye; Suet-Feung Chin; Jonathon Milner; Lindsay A Brown; Forrest Hsu; Blake Gilks; Torsten Nielsen; Michael Schulzer; Stephen Chia; Joseph Ragaz; Anthony Cahn; Lori Linger; Hilal Ozdag; Elena Cattaneo; Ekaterina S. Jordanova; Edward Schuuring; David S Yu; Ashok R Venkitaraman; Bruce A J Ponder; Aidan Doherty; Samuel A J R Aparicio; David Bentley; Charles Theillet; Chris P Ponting; Carlos Caldas; Tony Kouzarides
EMSY links the BRCA2 pathway to sporadic breast and ovarian cancer.
Cell 2003;115(5):523-35.
2003: Ivo A Olivotto; Boon Chua; Sharon J Allan; Caroline H Speers; Stephen Chia; Joseph Ragaz
Long-term survival of patients with supraclavicular metastases at diagnosis of breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):851-4.
1999: J Mark FitzGerald; R Kevin Elwood; Stephen Chia
Dialysis patients with tuberculosis.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne 1999;161(5):489.
1998: Stephen Chia; M Karim; R Kevin Elwood; J Mark FitzGerald
Risk of tuberculosis in dialysis patients: a population-based study.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1998;2(12):989-91.